Preferred Label : drug combinations;

Obsolete resource : false;

MeSH definition : Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.;

MeSH synonym : combinations, drug; Drug Combination; Combination, Drug;

MeSH annotation : IM for general only; NIM with specific drugs; differentiate from DRUG THERAPY, COMBINATION: drug combinations 2 or more drugs in a single dosage form; combination ther 2 or more drugs separately for a combined eff;;

Is substance : O;

Details


Main resources

You can consult :

Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.

https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/Recommandations%20SFPT%20Interactions%20Paxlovid.pdf
2022
France
practice guideline
Paxlovid
drug therapy, combination
combined modality therapy
health planning guidelines
drug combinations
drug, nos
Treatments
Treatments

---
https://sfpt-fr.org/recospaxlovid
2022
France
guideline
drug, nos
Treatments
health planning guidelines
combined modality therapy
Paxlovid
Treatments
drug combinations
drug therapy, combination

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/default-d6182e9e12-99.html
2021
false
false
false
Canada
French
drug evaluation
quebec
cystic fibrosis
adolescent
adult
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance regulator gene
CFTR delta F508
drug combinations
trikafta
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor, ivacaftor, tezacaftor drug combination
benzodioxoles
aminophenols
indoles
pyrazoles
pyridines
quinolines
benzodioxoles
aminophenols
drug combinations
indoles
pyrazoles
pyridines
quinolines

---
https://ansm.sante.fr/actualites/covid-19-extension-de-lutilisation-de-la-bitherapie-danticorps-monoclonaux-casirivimab-imdevimab-chez-certains-patients-hospitalises
2021
false
false
false
France
French
casirivimab and imdevimab drug combination
casirivimab and imdevimab
guidelines for drug use
summary of product characteristics
package leaflet
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal product form)
COVID-19
COVID-19
immunocompromised host
casirivimab and imdevimab drug combination
casirivimab
imdevimab
adult
aged
adolescent
Pre-Exposure Prophylaxis
Post-Exposure prophylaxis
inpatients
casirivimab and imdevimab drug combination
drug combinations
antibodies, monoclonal, humanized
coronavirus infections

---
https://www.has-sante.fr/jcms/p_3280914/fr/biktarvy-emtricitabine/-bictegravir-sodique/-tenofovir-alafenamide
2021
false
false
false
France
Emtricitabine
evaluation of the transparency committee
fumarates
Tenofovir
bictegravir
bictegravir
tenofovir alafenamide
tenofovir alafenamide
adenine
Heterocyclic Compounds, 4 or More Rings
bictegravir, emtricitabine, tenofovir alafenamide, drug combination
drug combinations

---
https://ansm.sante.fr/actualites/anticorps-monoclonaux-contre-la-covid-19-autorisation-en-acces-precoce-de-la-bitherapie-ronapreve-casirivimab-imdevimab-en-prophylaxie
2021
false
false
false
France
French
COVID-19
drug information
casirivimab and imdevimab drug combination
casirivimab
drug combinations
antibodies, monoclonal, humanized
imdevimab
Casirivimab/Imdevimab
risk assessment
COVID-19 aggravated
COVID-19
risk
infusions, intravenous
injections, subcutaneous
adult
adolescent
Pre-Exposure Prophylaxis
casirivimab and imdevimab drug combination
casirivimab and imdevimab
casirivimab and imdevimab drug combination
drug combinations
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal product form)

---
Authorization of Casirivimab and Imdevimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76129a-fra.php
2021
false
false
false
Canada
French
English
drug approval
canada
COVID-19
drug labeling
casirivimab
imdevimab
Casirivimab/Imdevimab
casirivimab and imdevimab drug combination
adult
adolescent
drug combinations
infusions, intravenous
drug information
casirivimab and imdevimab drug combination
coronavirus infections
antibodies, monoclonal, humanized
drug combinations

---
https://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Metastatic Pancreatic Adenocarcinoma
neoplasm metastasis
Pegylated Liposomal Irinotecan
Pegylated Liposomal Irinotecan
liposomes
pancreatic neoplasms
irinotecan sucrosofate
irinotecan sucrosofate
antineoplastic agents
antineoplastic agents
pregnancy
breast feeding
drug interactions
antineoplastic combined chemotherapy protocols
fluorouracil
leucovorin
Fluorouracil/Liposomal Irinotecan/Leucovorin Regimen
orphan drug production
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
aged
DNA topoisomerases, type I
survival analysis
drug evaluation, preclinical
drug approval
europe
Irinotecan hydrochloride trihydrate (substance)
adult
adenocarcinoma
camptothecin
camptothecin
drug combinations
sucrose
sucrose
camptothecin
drug combinations
sucrose

---
https://ansm.sante.fr/actualites/maladie-de-parkinson-remise-a-disposition-et-evolution-de-sinemet-lp-200-mg-50-mg
2021
false
false
false
France
French
drug information
carbidopa, levodopa drug combination
carbidopa
levodopa
drug combinations

---
https://www.ansm.sante.fr/actualites/anticorps-monoclonaux-lansm-permet-lutilisation-en-acces-precoce-de-deux-bitherapies-contre-la-covid-19
2021
false
false
false
France
French
scientific and technical information
drug information
antibodies, monoclonal
adult
Casirivimab/Imdevimab
Casirivimab
Imdevimab
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
Bamlanivimab
Etesevimab
aged
spike glycoprotein, coronavirus
france
drug monitoring
risk
drug combinations
casirivimab and imdevimab drug combination
COVID-19
COVID-19
casirivimab
imdevimab
casirivimab and imdevimab
drug combinations
antibodies, monoclonal, humanized
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal product form)
casirivimab and imdevimab drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61897454
2021
false
false
false
France
French
administration, oral
summary of product characteristics
package leaflet
telmisartan, hydrochlorothiazide drug combination
antihypertensive agents
telmisartan and diuretics
benzimidazoles
benzoates
hydrochlorothiazide
drug combinations
Telmisartan

---
https://www.has-sante.fr/jcms/p_3186049/fr/veille-des-etudes-cliniques-publiees-pour-certains-medicaments-du-covid-19
2021
false
false
false
France
coronavirus infections
pneumonia, viral
review of literature
hydroxychloroquine
remdesivir
lopinavir-ritonavir drug combination
Clinical Studies as Topic
azithromycin
remdesivir
pneumonia, viral
coronavirus infections
pandemics
alanine
alanine
ribonucleotides
ritonavir
lopinavir
drug combinations
COVID-19

---
https://www.has-sante.fr/jcms/p_3281544/fr/ronapreve-casirivimab-imdevimab-prophylaxie-pre-exposition-de-l-infection-a-sars-cov-2
https://has-sante.fr/jcms/p_3291779/fr/decision-n-2021-0259/dc/sem-du-7-octobre-2021-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ronapreve
2021
false
false
false
France
French
casirivimab and imdevimab drug combination
casirivimab and imdevimab
drug information
package leaflet
summary of product characteristics
guidelines for drug use
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal product form)
casirivimab and imdevimab drug combination
drug combinations
antibodies, monoclonal, humanized
casirivimab and imdevimab drug combination
treatment outcome
drug approval
Pre-Exposure Prophylaxis
COVID-19
injections, subcutaneous
infusions, intravenous
casirivimab
imdevimab
adult
adolescent

---
https://www.has-sante.fr/jcms/p_3282752/fr/symkevi-100-mg/150-mg-ivacaftor/-tezacaftor-mucoviscidose-6-ans
2021
false
false
false
France
evaluation of the transparency committee
aminophenols
drug combinations
indoles
quinolones
benzodioxoles
child
adolescent
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance regulator gene
cystic fibrosis
tezacaftor, ivacaftor drug combination
tezacaftor
ivacaftor
ivacaftor and tezacaftor
drug therapy, combination
treatment outcome
insurance, health, reimbursement
administration, oral

---
https://www.cochrane.org/fr/CD012775/SYMPT_quelles-sont-les-meilleures-associations-de-medicaments-dans-la-prevention-des-nausees-et-des
2021
United Kingdom
review of literature
french abstract
chemotherapy
disease
neoplasms
Chemotherapy
Cancer
drug, nos
neoplasm, malignant
cancer
antiemetics
Adult
drug combinations
nausea and vomiting
adulthood
protective agents
chemotherapy, nos
adult
drug therapy, combination
Adult

---
https://www.has-sante.fr/jcms/p_3224423/fr/epclusa
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
sofosbuvir-velpatasvir drug combination
antiviral agents
Product containing only sofosbuvir and velpatasvir in oral dose form (medicinal product form)
sofosbuvir and velpatasvir
hepatitis C, chronic
adult
adolescent
child
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings

---
https://www.has-sante.fr/jcms/p_3224398/fr/maviret
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
glecaprevir and pibrentasvir
Glecaprevir/Pibrentasvir
glecaprevir
pibrentasvir
antiviral agents
insurance, health, reimbursement
Duration of treatment (qualifier value)
hepatitis C, chronic
glecaprevir
benzimidazoles
quinoxalines
sulfonamides
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://www.has-sante.fr/jcms/p_3220388/fr/kaftrio-/-kalydeco
2020
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
ivacaftor
Chloride Channel Agonists
tezacaftor
ivacaftor
ivacaftor, tezacaftor and elexacaftor
cystic fibrosis
adolescent
adult
CFTR delta F508
cystic fibrosis transmembrane conductance regulator delta F508
administration, oral
elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
evaluation of the transparency committee
aminophenols
quinolones
indoles
benzodioxoles
cystic fibrosis transmembrane conductance regulator
pyrrolidines
pyridines
pyrazoles
drug combinations
quinolines

---
https://www.has-sante.fr/jcms/p_3215874/fr/costec
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
dorzolamide-timolol combination
dorzolamide-timolol combination
timolol, combinations
administration, ophthalmic
glaucoma, open-angle
ocular hypertension
exfoliation syndrome
adrenergic beta-antagonists
carbonic anhydrase inhibitors
evaluation of the transparency committee
sulfonamides
thiophenes
timolol
drug combinations
sulfonamides
thiophenes
timolol
drug combinations

---
https://www.has-sante.fr/jcms/p_3215576/fr/kaletra
2020
false
false
false
France
lopinavir and ritonavir
evaluation of the transparency committee
lopinavir-ritonavir drug combination
ritonavir
lopinavir
drug combinations

---
https://www.has-sante.fr/jcms/p_3191669/fr/revinty-ellipta
2020
false
false
false
France
drug combinations
fluticasone furoate
vilanterol
fluticasone furoate-vilanterol trifenatate
vilanterol and fluticasone furoate
evaluation of the transparency committee
androstadienes
benzyl alcohols
chlorobenzenes
drug combinations

---
https://www.has-sante.fr/jcms/p_3191663/fr/relvar-ellipta
2020
false
false
false
France
drug combinations
fluticasone furoate
vilanterol
fluticasone furoate-vilanterol trifenatate
vilanterol and fluticasone furoate
evaluation of the transparency committee
androstadienes
benzyl alcohols
chlorobenzenes
drug combinations

---
https://www.has-sante.fr/jcms/p_3191466/fr/lonsurf
2020
false
false
false
France
tipiracil
antimetabolites, antineoplastic
stomach neoplasms
Metastatic gastric cancer
insurance, health, reimbursement
treatment outcome
Gastroesophageal Junction Adenocarcinoma
trifluridine, combinations
evaluation of the transparency committee
trifluridine tipiracil drug combination
trifluridine
drug combinations
drug combinations
pyrrolidines
thymine

---
https://sfpt-fr.org/images/documents/STP/Recommandations_STP_ANRS_AC43_Pharmacologie_v2_26_03_20.pdf
2020
false
false
false
France
coronavirus infections
pneumonia, viral
lopinavir-ritonavir drug combination
guideline
hydroxychloroquine
drug monitoring
pandemics
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
COVID-19

---
https://ansm.sante.fr/actualites/medicaments-utilises-chez-les-patients-atteints-de-la-covid-19-une-surveillance-renforcee-des-effets-indesirables
2020
false
false
false
France
French
pharmacovigilance note
drug monitoring
Off-Label use
lopinavir-ritonavir drug combination
hydroxychloroquine
antiviral agents
cardiovascular diseases
pneumonia, viral
coronavirus infections
pandemics
ritonavir
lopinavir
drug combinations
pneumonia, viral
coronavirus infections
pandemics
COVID-19
COVID-19

---
https://ansm.sante.fr/uploads/2020/10/15/20201015-putlopinavir-ritonavir-1.pdf
2020
false
false
false
France
French
Off-Label use
lopinavir-ritonavir drug combination
guidelines for drug use
antiviral agents
drug interactions
lopinavir-ritonavir drug combination
lopinavir-ritonavir drug combination
risk
antiviral agents
antiviral agents
pregnancy
coronavirus infections
pneumonia, viral
ritonavir
lopinavir
drug combinations
pneumonia, viral
coronavirus infections
ritonavir
lopinavir
drug combinations
ritonavir
lopinavir
drug combinations
COVID-19
COVID-19

---
https://ansm.sante.fr/actualites/plaquenil-et-kaletra-les-traitements-testes-pour-soigner-les-patients-covid-19-ne-doivent-etre-utilises-qua-lhopital
2020
false
false
false
France
French
hydroxychloroquine
lopinavir-ritonavir drug combination
pharmacovigilance note
guidelines for drug use
hydroxychloroquine
arrhythmias, cardiac
drug monitoring
continuity of patient care
patients guideline
drug interactions
risk factors
coronavirus infections
pneumonia, viral
ritonavir
lopinavir
drug combinations
pneumonia, viral
coronavirus infections
COVID-19
COVID-19

---
https://www.ansm.sante.fr/actualites/lansm-securise-lacces-aux-traitements-plaquenil-et-kaletra-pour-les-patients-atteints-de-maladie-chronique
2020
false
false
false
France
French
hydroxychloroquine
lopinavir-ritonavir drug combination
arthritis, rheumatoid
hiv infections
lupus erythematosus, discoid
lupus erythematosus, cutaneous
Off-Label use
guidelines for drug use
chronic disease
ritonavir
lopinavir
drug combinations
pneumonia, viral
coronavirus infections
pneumonia, viral
coronavirus infections
COVID-19
COVID-19

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/kaletra-358.html
2020
false
false
false
Canada
treatment outcome
Evidence-Based medicine
lopinavir and ritonavir
drug evaluation
ritonavir
lopinavir
lopinavir-ritonavir drug combination
drug combinations
pneumonia, viral
coronavirus infections
pneumonia, viral
coronavirus infections
pandemics
drug combinations
COVID-19

---
https://www.has-sante.fr/jcms/p_3152692/fr/zavicefta
2020
false
false
false
France
French
drug combinations
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
avibactam
ceftazidime
avibactam, ceftazidime drug combination
anti-bacterial agents
beta-Lactamase Inhibitors
enterobacteriaceae infections
ceftazidime and beta-lactamase inhibitor
azabicyclo compounds
drug combinations

---
https://www.has-sante.fr/jcms/p_3152667/fr/epclusa
2020
false
false
false
France
Sofosbuvir
velpatasvir
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
hepatitis C, chronic
evaluation of the transparency committee
Epclusa
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2969204/fr/spiolto-respimat
2019
false
false
false
France
Tiotropium Bromide
olodaterol
tiotropium-olodaterol
drug combinations
administration, inhalation
olodaterol and tiotropium bromide
evaluation of the transparency committee
Spiolto Respimat
benzoxazines
drug combinations

---
https://www.has-sante.fr/jcms/p_3111988/fr/daivobet-xamiol
2019
false
false
false
France
drug combinations
betamethasone dipropionate, calcipotriol drug combination
insurance, health, reimbursement
evaluation of the transparency committee
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2963187/fr/gelox
2019
true
France
French
Gelox
drug combinations
administration, oral
insurance, health, reimbursement
treatment outcome
bentonite
aluminum hydroxide
magnesium hydroxide
antacids, other combinations
antacids
adult
gastroesophageal reflux
heartburn
dyspepsia
duodenogastric reflux
evaluation of the transparency committee
drug combinations

---
https://ansm.sante.fr/informations-de-securite/genvoya-r-stribild-r-risque-accru-dechec-virologique-et-secondairement-de-transmission-de-linfection-vih-de-la-mere-a-lenfant
2019
false
false
false
France
French
infectious disease transmission, vertical
treatment failure
hiv infections
pregnancy trimester, second
pregnancy trimester, third
hiv infections
pharmacovigilance note
anti-hiv agents
elvitegravir
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
guidelines for drug use
risk
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
pregnancy
infant, newborn
elvitegravir
Emtricitabine
Tenofovir
Cobicistat
drug combinations
quinolones
quinolones

---
https://www.has-sante.fr/portail/jcms/c_2899210/fr/diprosalic
2019
false
France
French
evaluation of the transparency committee
corticosteroid therapy
betamethasone dipropionate, salicylic acid drug combination
administration, cutaneous
salicylic acid
betamethasone
anti-inflammatory agents
betamethasone-17,21-dipropionate
psoriasis
lichenoid eruptions
dermatitis, seborrheic
betamethasone
treatment outcome
administration, topical
scalp dermatoses
adult
insurance, health, reimbursement
drug combinations
salicylates

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1248
2019
false
false
false
false
France
parkinson disease
case reports
journal article
levodopa
neutropenia
carbidopa
carbidopa, levodopa drug combination
drug combinations
carbidopa
levodopa
drug combinations

---
https://www.has-sante.fr/jcms/p_3103865/fr/invicorp
2019
false
false
false
France
French
evaluation of the transparency committee
adult
insurance, health, reimbursement
treatment outcome
erectile dysfunction
combinations
drug combinations
aviptadil
Phentolamine Mesylate
vasodilator agents
adrenergic alpha-antagonists
Intracavernous injection (procedure)
phentolamine
vasoactive intestinal peptide
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2969195/fr/paracetamol/codeine-teva
2019
false
false
false
France
drug combinations
acetaminophen
codeine
acetaminophen, codeine drug combination
evaluation of the transparency committee
drug combinations

---
https://www.has-sante.fr/jcms/p_3103865/fr/invicorp
2019
false
false
false
France
combinations
treatment outcome
aviptadil
aviptadil
erectile dysfunction
drug combinations
Phentolamine Mesylate
Phentolamine Mesylate
insurance, health, reimbursement
adult
evaluation of the transparency committee
phentolamine
phentolamine
vasoactive intestinal peptide
drug combinations
vasoactive intestinal peptide
drug combinations

---
https://www.has-sante.fr/jcms/p_3109935/fr/paracetamol-codeine-mylan
2019
false
false
false
France
insurance, health, reimbursement
evaluation of the transparency committee
acetaminophen, codeine drug combination
acetaminophen
codeine
drug combinations

---
https://www.has-sante.fr/jcms/p_3109937/fr/orkambi
2019
false
false
false
France
ivacaftor
lumacaftor
administration, oral
treatment outcome
insurance, health, reimbursement
child
cystic fibrosis
cystic fibrosis transmembrane conductance regulator delta F508
mutation
ivacaftor and lumacaftor
evaluation of the transparency committee
lumacaftor, ivacaftor drug combination
drug combinations
quinolones
benzodioxoles
aminophenols
aminopyridines
cystic fibrosis transmembrane conductance regulator

---
https://www.has-sante.fr/portail/jcms/c_1759931/fr/contraception-estroprogestative-transdermique-ou-vaginale-dispensation-en-officine
2019
false
false
false
France
French
guideline
administration, cutaneous
administration, intravaginal
transdermal patch
vaginal ring with progestogen and estrogen
contraception
drug combinations
ethinyl estradiol
progestins
professional role
pharmacists
contraceptive devices, female
vaginal rings
drug interactions
Ortho Evra
norelgestromin and ethinylestradiol
NuvaRing
minors
drug prescriptions
contraceptive devices, female
counseling
Contraindications, Procedure
norgestrel
norgestrel
drug combinations
desogestrel
desogestrel

---
https://www.has-sante.fr/jcms/p_3118137/fr/duodopa
2019
false
false
false
France
insurance, health, reimbursement
treatment outcome
carbidopa, levodopa drug combination
levodopa and decarboxylase inhibitor
parkinson disease
antiparkinson agents
dopamine agonists
enzyme inhibitors
dopa decarboxylase
evaluation of the transparency committee
carbidopa
levodopa
drug combinations

---
https://www.has-sante.fr/jcms/p_3115175/fr/epclusa
2019
false
false
false
France
sofosbuvir and velpatasvir
hepatitis C, chronic
evaluation of the transparency committee
sofosbuvir-velpatasvir drug combination
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings

---
https://www.has-sante.fr/jcms/p_3114479/fr/maviret
2019
false
false
false
France
French
insurance, health, reimbursement
treatment outcome
antiviral agents
Substance with Hepatitis C virus NS3/4A protease inhibitor mechanism of action (substance)
glecaprevir
pibrentasvir
administration, oral
glecaprevir and pibrentasvir
hepatitis C, chronic
adult
adolescent
renal insufficiency, chronic
Duration of treatment (qualifier value)
glecaprevir
quinoxalines
sulfonamides
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://www.has-sante.fr/portail/jcms/c_2970409/fr/cationorm-en-unidoses
2019
false
true
false
false
France
dry eye syndromes
Cationorm
Single Dose Vial
drug combinations
povidone
polyvinyl alcohol
keratoconjunctivitis
keratitis
dry eye syndromes
health technology assessment
polyvinyl alcohol
povidone

---
https://www.has-sante.fr/portail/jcms/c_2970412/fr/cationorm-en-flacon-multidose
2019
false
true
false
false
France
dry eye syndromes
Cationorm
drug combinations
polyvinyl alcohol
povidone
Multi Dose Vial
keratitis
keratoconjunctivitis
dry eye syndromes
health technology assessment
polyvinyl alcohol
povidone

---
https://www.has-sante.fr/jcms/p_3114485/fr/maviret
2019
false
false
false
France
glecaprevir and pibrentasvir
adult
adolescent
hepatitis C, chronic
glecaprevir
pibrentasvir
antiviral agents
insurance, health, reimbursement
treatment outcome
administration, oral
evaluation of the transparency committee
glecaprevir
quinoxalines
sulfonamides
benzimidazoles
glecaprevir and pibrentasvir
drug combinations
pyrrolidines

---
https://ansm.sante.fr/actualites/sinemet-levodopa-carbidopa-modification-des-comprimes-100mg-10mg-et-250mg-25mg
2019
false
false
false
France
French
pharmacovigilance note
carbidopa, levodopa drug combination
administration, oral
carbidopa
levodopa
drug combinations

---
Maintien du remboursement dans les mêmes conditions
https://www.has-sante.fr/portail/jcms/c_2896415/en/kaletra
2018
true
France
French
lopinavir-ritonavir drug combination
lopinavir-ritonavir drug combination
infant, newborn
infant
child, preschool
lopinavir and ritonavir
adult
adolescent
child
hiv infections
anti-hiv agents
insurance, health, reimbursement
treatment outcome
HIV-1
drug therapy, combination
anti-hiv agents
administration, oral
evaluation of the transparency committee
ritonavir
lopinavir
drug combinations
ritonavir
lopinavir
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2893466/fr/spifen
2018
true
France
French
-
adult
child
treatment outcome
other analgesics and antipyretics
ibuprofen
administration, oral
-
-
ibuprofen
pain
migraine disorders
insurance, health, reimbursement
fever
ibuprofen arginine
arginine
drug combinations
evaluation of the transparency committee
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2875371/fr/moduretic
2018
false
false
false
France
amiloride, hydrochlorothiazide drug combination
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
moduretic
amiloride
hydrochlorothiazide
drug combinations

---
https://ansm.sante.fr/actualites/ruptures-de-stock-prolongees-de-sinemet-levodopa-carbidopa-lansm-met-en-place-un-plan-dactions-afin-deviter-toute-interruption-de-traitement-chez-les-patients-concernes
2018
false
false
false
false
France
French
drug information
patients guideline
carbidopa, levodopa drug combination
administration, oral
antiparkinson agents
levodopa and decarboxylase inhibitor
parkinson disease
parkinsonian disorders
carbidopa
levodopa
drug combinations

---
https://ansm.sante.fr/informations-de-securite/sinemet-recommandations-aux-professionnels-de-sante-dans-le-contexte-des-ruptures-de-stocks
2018
false
false
false
France
French
carbidopa, levodopa drug combination
carbidopa, levodopa drug combination
guidelines for drug use
antiparkinson agents
antiparkinson agents
levodopa and decarboxylase inhibitor
parkinson disease
drugs, generic
carbidopa
levodopa
drug combinations
carbidopa
levodopa
drug combinations

---
https://www.ansm.sante.fr/actualites/ruptures-de-stock-prolongees-de-sinemet-levodopa-carbidopa-lansm-met-en-place-un-plan-dactions-afin-deviter-toute-interruption-de-traitement-chez-les-patients-concernes
2018
false
false
false
France
French
drug information
guideline
carbidopa, levodopa drug combination
administration, oral
antiparkinson agents
levodopa and decarboxylase inhibitor
parkinson disease
parkinsonian disorders
carbidopa
levodopa
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2862997/fr/relvar-ellipta-revinty-ellipta
2018
false
France
French
vilanterol
fluticasone furoate
drug combinations
treatment outcome
glucocorticoids
asthma
adult
adolescent
administration, inhalation
adrenergic beta-2 receptor agonists
androstadienes
benzyl alcohols
chlorobenzenes
vilanterol and fluticasone furoate
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
evaluation of the transparency committee
insurance, health, reimbursement
fluticasone furoate-vilanterol trifenatate
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2844528/fr/auricularum-oxytetracycline-polymyxine-b-dexamethasone-nystatine-anti-infectieux-et-corticoide-en-association
https://www.has-sante.fr/portail/jcms/c_2844528/fr/auricularum-peri-operatoire
2018
false
false
false
false
France
French
evaluation of the transparency committee
instillation, drug
dexamethasone and antiinfectives
auricularum
otitis externa
perioperative period
chronic disease
otitis
ear
perioperative care
treatment outcome
insurance, health, reimbursement
anti-inflammatory agents
glucocorticoids
anti-bacterial agents
antifungal agents
administration, topical
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
guidelines for drug use
Otomycosis (disorder)
nystatin
oxytetracycline
polymyxin B
dexamethasone
dexamethasone
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2856003/fr/moducren
2018
false
false
false
false
France
French
evaluation of the transparency committee
moducrin
insurance, health, reimbursement
treatment outcome
amiloride
hydrochlorothiazide
timolol
drug combinations

---
Inscription d'une solution buvable adaptée à l’extension d’indication chez les jeunes enfants et nourrissons âgés de 14 jours à 2 ans.
https://www.has-sante.fr/portail/jcms/c_2831910/fr/kaletra
2018
false
France
French
lopinavir-ritonavir drug combination
lopinavir-ritonavir drug combination
infant, newborn
infant
child, preschool
lopinavir and ritonavir
hiv infections
anti-hiv agents
insurance, health, reimbursement
treatment outcome
HIV-1
drug therapy, combination
anti-hiv agents
administration, oral
evaluation of the transparency committee
ritonavir
lopinavir
drug combinations
ritonavir
lopinavir
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2823761/fr/perindopril/indapamide-arrow-lab
2018
false
false
false
false
France
French
evaluation of the transparency committee
indapamide, perindopril drug combination
indapamide
perindopril
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2885789/fr/rifater
2018
false
false
false
France
drug hypersensitivity syndrome
administration, oral
rifampicin, pyrazinamide and isoniazid
evaluation of the transparency committee
rifater
isoniazid, pyrazinamide, rifampin drug combination
isoniazid
pyrazinamide
rifampin
drug combinations
isoniazid, pyrazinamide, rifampin drug combination
isoniazid
pyrazinamide
rifampin
drug combinations

---
http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKi-juillet2018/JAK_14_Association_Med_VDEF_1218.pdf
2018
France
guideline
drug therapy, combination
disease management
arthritis, rheumatoid
Rheumatoid arthritis
temperance
severe
drug combinations
drug, nos
Polyarthritis

---
https://www.has-sante.fr/portail/jcms/c_2824476/fr/anti-infectieux-associes-a-un-corticoide-en-gouttes-auriculaires-polydexa-neomycine-polymyxine-b-dexamethasone
https://www.has-sante.fr/portail/jcms/c_2824476/fr/polydexa
2017
false
false
France
French
evaluation of the transparency committee
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
guidelines for drug use
Acute bacterial otitis externa (disorder)
Acute fungal otitis externa (disorder)
dexamethasone-21-sulfobenzoate, sodium salt
dexamethasone, neomycin, polymyxin B drug combination
administration, topical
drug combinations
anti-bacterial agents
dexamethasone
dexamethasone-21-sulfobenzoate
polymyxin B
polymyxin B sulfate
Neomycin Sulfate
neomycin
glucocorticoids
insurance, health, reimbursement
otitis externa
dexamethasone and antiinfectives
dexamethasone
dexamethasone-21-sulfobenzoate
drug combinations

---
https://www.revmed.ch/RMS/2017/RMS-N-552/ARNI-nouvelle-abreviation-pour-un-nouveau-traitement-de-l-insuffisance-cardiaque
2017
false
false
false
Switzerland
French
heart failure
angiotensin receptor antagonists
neprilysin
sacubitril and valsartan sodium hydrate drug combination
valsartan and sacubitril
treatment outcome
Left ventricular failure
journal article
algorithms
heart failure
Left ventricular ejection fraction (observable entity)
drug combinations
Renin-Angiotensin-Aldosterone system
natriuretic peptides
renin-angiotensin system
aminobutyrates
tetrazoles

---
https://www.has-sante.fr/portail/jcms/c_2806292/fr/divina-duova
2017
false
false
false
France
French
evaluation of the transparency committee
divina
drug combinations
estradiol
medroxyprogesterone

---
https://www.has-sante.fr/portail/jcms/c_2805042/fr/paracetamol-codeine-arrow
2017
false
false
false
France
French
evaluation of the transparency committee
codeine
acetaminophen
acetaminophen, codeine drug combination
codeine
acetaminophen
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2798157/fr/pergoveris
2017
false
false
false
France
French
evaluation of the transparency committee
pergoveris
follicle stimulating hormone
luteinizing hormone
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2666630/fr/contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
2017
false
false
false
France
French
scientific and technical information
medical
medical devices
drug therapy, combination
drug combinations
drug, nos
drug evaluation
device, nos
equipment and supplies
has patient
societies, medical
patients

---
https://pharmacomedicale.org/medicaments/par-specialites/item/sulfadoxine-pyrimethamine
2017
false
true
false
France
fanasil, pyrimethamine drug combination
pyrimethamine, combinations
antimalarials
antimalarials
antimalarials
drug information
pyrimethamine
sulfadoxine
fanasil, pyrimethamine drug combination
drug combinations
pyrimethamine
sulfadoxine
drug combinations
pyrimethamine
sulfadoxine
drug combinations

---
https://www.minerva-ebp.be/FR/Article/2115
2017
false
false
false
false
Belgium
French
critical appraisal or critical reading
drug combinations
pulmonary disease, chronic obstructive
treatment outcome
administration, inhalation
glycopyrrolate
Formoterol Fumarate
bronchodilator agents
glucocorticoids
beclomethasone
disease exacerbation
pulmonary disease, chronic obstructive
forced expiratory volume
muscarinic antagonists
comparative effectiveness research

---
http://www.has-sante.fr/portail/jcms/c_2751845/fr/codoliprane
2017
false
false
false
France
French
evaluation of the transparency committee
acetaminophen, codeine drug combination
codeine and paracetamol
administration, oral
acetaminophen
codeine
drug combinations

---
http://www.academie-medecine.fr/wp-content/uploads/2017/03/17.2.28-BOUVENOT-communiqué-site.pdf
2017
false
false
false
France
French
practice guideline
drug prescriptions
drug combinations
drug therapy, combination
treatment outcome
risk assessment
adult

---
http://www.has-sante.fr/portail/jcms/c_2743859/fr/paracetamol-codeine-sandoz
2017
false
false
false
France
French
evaluation of the transparency committee
paracetamol, combinations excl. psycholeptics
acetaminophen
acetaminophen
acetaminophen, codeine drug combination
codeine
codeine
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2824491/fr/anti-infectieux-associes-a-un-corticoide-en-gouttes-auriculaires-auricularum-oxytetracycline-polymyxine-b-nystatine-dexamethasone-otite-externe
https://www.has-sante.fr/portail/jcms/c_2824491/fr/auricularum-otite-externe
2017
false
true
false
false
France
French
evaluation of the transparency committee
instillation, drug
dexamethasone and antiinfectives
auricularum
otitis externa
chronic disease
otitis
ear
treatment outcome
insurance, health, reimbursement
anti-inflammatory agents
glucocorticoids
anti-bacterial agents
antifungal agents
administration, topical
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
guidelines for drug use
Acute fungal otitis externa (disorder)
Acute bacterial otitis externa (disorder)
nystatin
oxytetracycline
polymyxin B
dexamethasone
dexamethasone
drug combinations
drug combinations

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
https://www.ema.europa.eu/medicines/human/EPAR/lopinavirritonavir-mylan
2016
false
United Kingdom
French
English
syndication feed
drugs, generic
Product containing lopinavir and ritonavir (medicinal product)
human immunodeficiency virus i infection
Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)
lopinavir
lopinavir
lopinavir-ritonavir drug combination
lopinavir-ritonavir drug combination
acquired immunodeficiency syndrome
adult
child
drug interactions
hiv protease inhibitors
anti-hiv agents
treatment outcome
drug evaluation
drug combinations
ritonavir
administration, oral
hiv infections
adolescent
anti-hiv agents
hiv protease inhibitors
drug therapy, combination
pregnancy
breast feeding
drug evaluation, preclinical
drug approval
HIV-1
ritonavir
package leaflet
summary of product characteristics
drug evaluation
lopinavir and ritonavir
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2612472/fr/rifater
http://www.has-sante.fr/portail/jcms/c_461162/fr/rifater
http://www.has-sante.fr/portail/jcms/c_399103/fr/rifater-comprime-enrobe-boite-de-60
2016
false
true
false
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
treatment outcome
isoniazid, pyrazinamide, rifampin drug combination
drug combinations
rifampicin, pyrazinamide and isoniazid
tuberculosis
tuberculosis, pulmonary
antitubercular agents
isoniazid
pyrazinamide
rifampin
antibiotic therapy
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2630429/fr/quelle-place-pour-les-associations-fixes-corticoide-/-beta-2-mimetique-de-longue-duree-d-action-dans-le-traitement-de-la-bronchopneumopathie-chronique-obstructive
2016
false
false
false
France
French
guidelines for drug use
pulmonary disease, chronic obstructive
drug combinations
formoterol and beclometasone
formoterol and budesonide
Budesonide, Formoterol Fumarate Drug Combination
administration, inhalation
Formoterol Fumarate
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
salmeterol and fluticasone
vilanterol and fluticasone furoate
Fluticasone
vilanterol
beclomethasone
glucocorticoids
adrenergic beta-2 receptor agonists
treatment outcome
benzyl alcohols
chlorobenzenes

---
http://www.has-sante.fr/portail/jcms/c_2617874/fr/targinact
2016
false
France
French
evaluation of the transparency committee
Naloxone Hydrochloride
Oxycodone Hydrochloride
restless legs syndrome
oxycodone naloxone combination
drug combinations
Delayed-Action preparations
oxycodone
naloxone
administration, oral
narcotics
insurance, health, reimbursement
adult
treatment outcome
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2656337/fr/orkambi
http://www.has-sante.fr/portail/jcms/c_2656337/fr/orkambi-lumacaftor-/-ivacaftor-correcteur-et-potentialisateur-du-gene-cftr
2016
false
false
false
France
French
drug combinations
aminophenols
aminopyridines
aminopyridines
aminophenols
quinolones
quinolones
benzodioxoles
benzodioxoles
adolescent
adult
CFTR gene.p.F508 del
cystic fibrosis transmembrane conductance regulator
cystic fibrosis transmembrane conductance regulator delta F508
cystic fibrosis
ivacaftor
ivacaftor
treatment outcome
ivacaftor and lumacaftor
lumacaftor, ivacaftor drug combination
lumacaftor, ivacaftor drug combination
evaluation of the transparency committee
insurance, health, reimbursement
forced expiratory volume
guidelines for drug use
orphan drug production
lumacaftor
lumacaftor
cystic fibrosis transmembrane conductance regulator
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676717/fr/paracetamol-codeine-biogaran-ref
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
codeine
codeine
acetaminophen
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676699/fr/paracetamol-codeine-teva
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
acetaminophen
codeine
codeine
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676690/fr/paracetamol-codeine-eg
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
codeine
codeine
acetaminophen
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676684/fr/paracetamol-codeine-mylan
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
codeine
codeine
acetaminophen, codeine drug combination
acetaminophen
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676678/fr/paracetamol-codeine-cristers
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
acetaminophen
codeine
codeine
drug combinations

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00329
2016
false
false
false
Canada
French
drug information
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings

---
http://www.has-sante.fr/portail/jcms/c_2666630/en/contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
http://www.has-sante.fr/portail/jcms/c_2681820/en/guide-pour-les-associations-de-patients-et-d-usagers-contribution-aux-evaluations-des-produits-de-sante
http://www.has-sante.fr/portail/jcms/c_2720917/en/methode-d-elaboration-par-la-has-contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
2016
false
false
false
France
French
handbooks
drug therapy, combination
drug combinations
patients
societies, medical
drug evaluation
device, nos
medical devices
equipment and supplies
has patient
medical
drug, nos

---
http://www.has-sante.fr/portail/jcms/c_2676753/fr/algisedal
2016
false
France
French
child
adolescent
pregnancy
pain
treatment outcome
moderate pain
severe pain
breast feeding
CYP2D6 ultrarapid metabolizer status
codeine and paracetamol
tablets
administration, oral
drug combinations
acetaminophen, codeine drug combination
codeine
acetaminophen
analgesics, non-narcotic
analgesics, opioid
adult
insurance, health, reimbursement
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2724396/fr/epclusa
http://www.has-sante.fr/portail/jcms/c_2724396/fr/epclusa-sofosbuvir/velpatasvir-association-fixe-d-antiviraux-a-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
drug combinations
Sofosbuvir
Sofosbuvir
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
velpatasvir
velpatasvir
hepatitis C, chronic
adult
guidelines for drug use
sofosbuvir-velpatasvir drug combination
sofosbuvir-velpatasvir drug combination
sofosbuvir and velpatasvir
carbamates
Heterocyclic Compounds, 4 or More Rings
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2724390/fr/zepatier
http://www.has-sante.fr/portail/jcms/c_2724390/fr/zepatier-elbasvir/grazoprevir-association-fixe-d-antiviraux-a-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
elbasvir
elbasvir
drug combinations
antiviral agents
antiviral agents
hepatitis C, chronic
administration, oral
benzofurans
benzofurans
imidazoles
imidazoles
quinoxalines
quinoxalines
treatment outcome
adult
hepatitis C, chronic
insurance, health, reimbursement
guidelines for drug use
elbasvir-grazoprevir drug combination
elbasvir-grazoprevir drug combination
elbasvir and grazoprevir
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2730770/fr/malarone
2016
false
false
false
France
French
evaluation of the transparency committee
atovaquone
malarone
atovaquone, proguanil drug combination
proguanil
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2732140/fr/liptruzet
2016
false
false
false
France
French
evaluation of the transparency committee
liptruzet
azetidines
heptanoic acids
pyrroles
drug combinations

---
https://www.revmed.ch/RMS/2016/RMS-N-527/Combinaison-gliptine-gliflozine-dans-le-traitement-du-diabete-de-type-2
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
drug combinations
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
treatment outcome
saxagliptin and dapagliflozin
dapagliflozin
saxagliptin
Linagliptin
linagliptin and empagliflozin
empagliflozin
Product containing empagliflozin and linagliptin (medicinal product)
administration, oral
Sodium-Glucose transporter 2
Sodium-Glucose Transporter 2 Inhibitors
dapagliflozin
dapagliflozin
dipeptides
adamantane
adamantane
benzhydryl compounds
glucosides

---
http://www.has-sante.fr/portail/jcms/c_2559109/fr/kivexa
2015
false
false
false
France
French
evaluation of the transparency committee
dideoxynucleosides
lamivudine
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2022230/fr/prinzide
http://www.has-sante.fr/portail/jcms/c_854100/prinzide
2015
false
France
French
hydrochlorothiazide, lisinopril drug combination
lisinopril and diuretics
hypertension
hydrochlorothiazide
lisinopril
antihypertensive agents
drug combinations
diuretics
angiotensin-converting enzyme inhibitors
administration, oral
insurance, health, reimbursement
sodium chloride symporter inhibitors
evaluation of the transparency committee
drug combinations

---
https://www.ema.europa.eu/medicines/human/EPAR/Orkambi
2015
false
false
false
United Kingdom
French
English
summary of product characteristics
package leaflet
drug combinations
aminophenols
aminopyridines
aminopyridines
aminophenols
quinolones
quinolones
benzodioxoles
benzodioxoles
continuity of patient care
adolescent
adult
CFTR gene.p.F508 del
cystic fibrosis transmembrane conductance regulator
cystic fibrosis transmembrane conductance regulator delta F508
cystic fibrosis
ivacaftor
ivacaftor
drug evaluation
syndication feed
drug approval
europe
treatment outcome
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
product surveillance, postmarketing
ivacaftor and lumacaftor
lumacaftor, ivacaftor drug combination
lumacaftor, ivacaftor drug combination
lumacaftor
lumacaftor
cystic fibrosis transmembrane conductance regulator
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2585417/fr/auricularum
http://www.has-sante.fr/portail/jcms/c_400288/fr/auricularum
http://www.has-sante.fr/portail/jcms/c_2585417/fr/auricularum-oxytetracycline-polymyxine-b-dexamethasone-nystatine-association-fixe-d-antibiotiques-antimycosique-corticoide
2015
false
true
false
false
France
French
evaluation of the transparency committee
instillation, drug
dexamethasone and antiinfectives
auricularum
otitis externa
perioperative period
chronic disease
otitis
ear
perioperative care
treatment outcome
insurance, health, reimbursement
anti-inflammatory agents
glucocorticoids
anti-bacterial agents
antifungal agents
administration, topical
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
guidelines for drug use
nystatin
oxytetracycline
polymyxin B
dexamethasone
dexamethasone
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2040751/fr/daivobet
2015
true
France
French
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2037318/fr/spifen
2015
true
France
French
-
adult
child
treatment outcome
antimigraine preparations
ibuprofen
administration, oral
-
-
other antimigraine preparations
ibuprofen
pain
migraine disorders
insurance, health, reimbursement
fever
ibuprofen arginine
arginine
drug combinations
evaluation of the transparency committee
drug combinations

---
https://www.ema.europa.eu/medicines/human/EPAR/Mysimba
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
naltrexone
naltrexone
bupropion
bupropion
anti-obesity agents
anti-obesity agents
product surveillance, postmarketing
adult
overweight
obesity
overweight
body mass index
administration, oral
Delayed-Action preparations
appetite
energy metabolism
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
bupropion hydrochloride, naltrexone hydrochoride drug combination
bupropion hydrochloride, naltrexone hydrochoride drug combination
bupropion and naltrexone
Product containing bupropion and naltrexone in oral dose form (medicinal product form)
drug combinations
drug combinations
naltrexone
bupropion

---
http://www.has-sante.fr/portail/jcms/c_2031539/fr/dualkopt
2015
false
false
false
France
French
evaluation of the transparency committee
timolol, combinations
dorzolamide hydrochloride-timolol maleate combination
dorzolamide hydrochloride-timolol maleate combination
dorzolamide-timolol combination
dorzolamide-timolol combination
dorzolamide
dorzolamide
ophthalmic solutions
administration, ophthalmic
adrenergic beta-antagonists
adrenergic beta-antagonists
carbonic anhydrase inhibitors
carbonic anhydrase inhibitors
treatment outcome
insurance, health, reimbursement
ocular hypertension
exfoliation syndrome
glaucoma, open-angle
drug combinations
sulfonamides
thiophenes
timolol
drug combinations
sulfonamides
thiophenes
timolol

---
http://www.has-sante.fr/portail/jcms/c_2017120/fr/velphoro
http://www.has-sante.fr/portail/jcms/c_2017120/fr/velphoro-oxyhydroxyde-sucro-ferrique-hypophosphoremiant
2015
false
false
false
France
French
evaluation of the transparency committee
sucroferric oxyhydroxide
administration, oral
hyperphosphatemia
renal insufficiency, chronic
renal dialysis
peritoneal dialysis
treatment outcome
insurance, health, reimbursement
guidelines for drug use
sucroferric oxyhydroxide
sucroferric oxyhydroxide
drug combinations
ferric compounds
sucrose
drug combinations
ferric compounds
sucrose

---
https://www.ema.europa.eu/medicines/human/EPAR/Numient
2015
false
United Kingdom
English
French
drug approval
europe
summary of product characteristics
package leaflet
drug evaluation
syndication feed
carbidopa
levodopa
adult
carbidopa, levodopa drug combination
Aromatic Amino Acid Decarboxylase Inhibitors
Aromatic Amino Acid Decarboxylase Inhibitors
treatment outcome
carbidopa
carbidopa, levodopa drug combination
levodopa
administration, oral
drug combinations
levodopa and decarboxylase inhibitor
dopa decarboxylase
antiparkinson agents
dopamine agents
insurance, health, reimbursement
drug combinations
drug combinations

---
https://www.ema.europa.eu/medicines/human/EPAR/Velphoro
2014
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
sucroferric oxyhydroxide
drug approval
europe
administration, oral
Chewable Tablet Dosage Form
hyperphosphatemia
adult
renal insufficiency
drug therapy, combination
bone diseases
peritoneal dialysis
renal dialysis
chelating agents
chelating agents
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
sucroferric oxyhydroxide
sucroferric oxyhydroxide
drug combinations
ferric compounds
sucrose
drug combinations
ferric compounds
sucrose

---
http://www.has-sante.fr/portail/jcms/c_1753126/fr/divina-duova
2014
false
France
French
postmenopause
estrogens
divina
drug combinations
administration, oral
medroxyprogesterone and estrogen
medroxyprogesterone and estrogen
medroxyprogesterone acetate
estradiol
hormone replacement therapy
insurance, health, reimbursement
estrogens
progesterone congeners
osteoporosis, postmenopausal
osteoporotic fractures
evaluation of the transparency committee
drug combinations
estradiol
medroxyprogesterone

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/40839a-fra.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/40841a-fra.php
2014
false
false
false
Canada
French
NuvaRing
etonogestrel
administration, intravaginal
contraceptive devices, female
risk factors
thrombosis
vaginal ring with progestogen and estrogen
pharmacovigilance note
Contraindications, Procedure
drug combinations
ethinyl estradiol
desogestrel
desogestrel
Contraindications, Drug

---
http://www.has-sante.fr/portail/jcms/c_1750090/fr/coveram
http://www.has-sante.fr/portail/jcms/c_840942/coveram
2014
false
France
French
amlodipine
Amlodipine Besylate
arginine
perindopril
amlodipine
arginine
perindopril
amlodipine, perindopril drug combination
antihypertensive agents
amlodipine, perindopril drug combination
amlodipine
drug combinations
perindopril and amlodipine
perindopril
administration, oral
insurance, health, reimbursement
treatment outcome
hypertension
coronary artery disease
calcium channel blockers
angiotensin-converting enzyme inhibitors
Amlodipine Besylate
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1774141/fr/omacor
2014
false
France
French
drug combinations
docosahexaenoic acids
Omacor
eicosapentaenoic acid
omega-3-triglycerides incl. other esters and acids
insurance, health, reimbursement
hypertriglyceridemia
adult
myocardial infarction
treatment outcome
drug therapy, combination
alpha-Tocopherol
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1743051/fr/xamiol
http://www.has-sante.fr/portail/jcms/c_778871/xamiol
2014
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
administration, topical
insurance, health, reimbursement
treatment outcome
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
psoriasis
scalp dermatoses
adult
meta-analysis as topic
glucocorticoids
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1739166/fr/pediazole
http://www.has-sante.fr/portail/jcms/c_399647/fr/pediazole-granule-pour-sirop-flacon-de-200-ml
2014
false
false
false
France
French
evaluation of the transparency committee
acetyl sulfisoxazole
drug combinations
administration, oral
insurance, health, reimbursement
MK 0641
erythromycin ethylsuccinate
anti-bacterial agents
sulfonamides, combinations with other antibacterials (excl. trimethoprim)
treatment outcome
otitis media
acute disease
haemophilus infections
haemophilus influenzae
child
Otitis media acute
antibiotic therapy
acetyl sulfisoxazole
erythromycin
sulfisoxazole
drug combinations
sulfisoxazole

---
https://www.ema.europa.eu/medicines/human/EPAR/Ryzodeg
2013
false
United Kingdom
English
French
insulin degludec and insulin aspart
insulin degludec, insulin aspart drug combination
insulin degludec, insulin aspart drug combination
insulin aspart
drug combinations
drug approval
europe
treatment outcome
insulin, long-acting
insulin, long-acting
hypoglycemic agents
hypoglycemic agents
injections, subcutaneous
diabetes mellitus, type 1
diabetes mellitus, type 2
summary of product characteristics
package leaflet
drug evaluation
syndication feed
recombinant proteins
adult
aged
drug interactions
pregnancy
breast feeding
fertility
randomized controlled trials as topic
Glycated Hemoglobin
drug combinations
drug combinations
insulin aspart
insulin degludec
insulin degludec

---
https://www.ema.europa.eu/medicines/human/EPAR/Relvar-Ellipta
2013
false
United Kingdom
French
English
vilanterol
fluticasone furoate
drug combinations
drug approval
europe
treatment outcome
fluticasone furoate
glucocorticoids
glucocorticoids
vilanterol
asthma
adult
adolescent
pulmonary disease, chronic obstructive
summary of product characteristics
package leaflet
drug evaluation
syndication feed
administration, inhalation
product surveillance, postmarketing
drug monitoring
drug interactions
pregnancy
breast feeding
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
clinical trials, phase iii as topic
drug evaluation, preclinical
androstadienes
androstadienes
benzyl alcohols
benzyl alcohols
chlorobenzenes
chlorobenzenes
vilanterol and fluticasone furoate
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
fluticasone furoate-vilanterol trifenatate
fluticasone furoate-vilanterol trifenatate
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1329540/teysuno
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/teysuno__03102012_avis_ct12048.pdf
2012
false
France
French
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
drug combinations
administration, oral
gimeracil
gimeracil
adult
stomach neoplasms
antineoplastic combined chemotherapy protocols
tegafur
tegafur
oxonic acid
oxonic acid
tegafur, combinations
antineoplastic agents
antineoplastic agents
insurance, health, reimbursement
evaluation of the transparency committee
treatment outcome
randomized controlled trials as topic
survival analysis
pyridines
pyridines
drug combinations
drug combinations

---
https://www.ema.europa.eu/medicines/human/EPAR/Ganfort
2012
false
United Kingdom
French
English
syndication feed
ganfort
ganfort
Bimatoprost
Bimatoprost
glaucoma, open-angle
ocular hypertension
timolol
timolol
adrenergic beta-antagonists
adrenergic beta-antagonists
antihypertensive agents
antihypertensive agents
treatment outcome
drug evaluation
drug combinations
drug labeling
drug approval
ophthalmic solutions
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
timolol, combinations
timolol maleate
timolol maleate
administration, ophthalmic
package leaflet
drug evaluation
summary of product characteristics
amides
cloprostenol
cloprostenol
drug combinations
amides
cloprostenol
drug combinations

---
https://www.ema.europa.eu/medicines/human/EPAR/Rasilez-HCT
2012
United Kingdom
French
English
syndication feed
antihypertensive agents
amides
diuretics
fumarates
hydrochlorothiazide
drug combinations
hydrochlorothiazide
amides
fumarates
tablets
administration, oral
adult
drug approval
aliskiren
aliskiren
breast feeding
diuretics
renin
drug evaluation, preclinical
treatment outcome
drug labeling
aged
drug interactions
pregnancy
aliskiren and hydrochlorothiazide
amides
fumarates
package leaflet
drug evaluation
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Teysuno
2012
false
United Kingdom
French
English
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
syndication feed
tegafur
gimeracil
oxonic acid
drug combinations
gimeracil
tegafur
oxonic acid
drug approval
treatment outcome
pyridines
pyridines
tegafur, combinations
administration, oral
adult
antineoplastic agents
antineoplastic agents
stomach neoplasms
antineoplastic combined chemotherapy protocols
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pyridines
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug combinations

---
https://www.revmed.ch/RMS/2012/RMS-360/Sommes-nous-prets-a-prescrire-une-polypill-a-nos-patients
2012
Switzerland
French
journal article
cardiovascular diseases
secondary prevention
medication adherence
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1231626/ganfort
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/ganfort_29022012_avis_ct10497.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_460037
2012
false
France
French
evaluation of the transparency committee
Bimatoprost
ganfort
ophthalmic solutions
drug combinations
amides
cloprostenol
antihypertensive agents
timolol maleate
adrenergic beta-antagonists
timolol
insurance, health, reimbursement
glaucoma, open-angle
ocular hypertension
timolol, combinations
administration, ophthalmic
drug combinations

---
https://www.minerva-ebp.be/fr/article/233
2011
false
true
false
false
minerva-ebm.be
Belgium
child
child, preschool
respiratory tract infections
camphor, cedar leaf oil, eucalyptus oil, menthol, myristica oil, terebinth oil, thymol drug combination
critical appraisal or critical reading
ointments
cough
plant extracts
terpenes
drug combinations

---
https://www.minerva-ebp.be/fr/article/356
2009
false
false
minerva-ebm.be
Belgium
French
atrial fibrillation
aspirin
atrial fibrillation
drug combinations
critical appraisal or critical reading

---
http://www.has-sante.fr/portail/jcms/c_719595/kivexa
2008
France
French
abacavir
abacavir, lamivudine drug combination
HLA-B*57:01 antigen
reverse transcriptase inhibitors
lamivudine
dideoxynucleosides
drug combinations
administration, oral
tablets
genetic testing
anti-hiv agents
HLA-B antigens
hiv infections
drug therapy, combination
adult
adolescent
drug hypersensitivity
lamivudine and abacavir
abacavir sulfate
dideoxynucleosides
HLA-B antigens
evaluation of the transparency committee

---
http://www.lecrat.eu/?s=Pilobloq%C2%AE
2008
France
French
adrenergic beta-antagonists
timolol
pilocarpine
pregnancy
breast feeding
drug combinations
antihypertensive agents
miotics
timolol, combinations
drug information

---
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:328:0042:0048:FR:PDF
2008
legislation
drug utilization
drug therapy, combination
plant preparations
drug combinations

---
http://www.has-sante.fr/portail/display.jsp?id=c_603111
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4879_intetrix_.pdf
2007
France
French
drug combinations
intetrix
tilbroquinol
oxyquinoline
administration, oral
insurance, health, reimbursement
tilbroquinol
5-methyl-8-hydroxyquinoline
adult
dysentery, amebic
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_487033
2007
France
French
drug combinations
erysimum
plant extracts
antitussive agents
pharmaceutical solutions
codeine
opium alkaloids and derivatives
evaluation of the transparency committee

---
https://www.cadth.ca/sites/default/files/pdf/385_steroids_tr_fr.pdf
https://www.cadth.ca/sites/default/files/pdf/385_steroids_appendices_fr.pdf
https://www.cadth.ca/fr/association-dun-ss2-agoniste-action-prolongee-baap-et-dun-corticosteroide-en-comparaison-un-baap
2007
true
Canada
French
Adrenocortical steroid therapy
corticosteroid therapy
drug combinations
adrenal cortex hormones
pulmonary disease, chronic obstructive
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_400861
2006
France
French
drug combinations
erysimum
plant extracts
antitussive agents
capsules
codeine
opium alkaloids and derivatives
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400267
2005
France
French
drug combinations
antihypertensive agents
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
tablets
tetrahydroisoquinolines
angiotensin-converting enzyme inhibitors
quinapril and diuretics
evaluation of the transparency committee
Quinapril

---
http://www.has-sante.fr/portail/display.jsp?id=c_400184
2005
France
French
drug combinations
diuretics
hydrochlorothiazide
tablets
tetrahydroisoquinolines
angiotensin-converting enzyme inhibitors
sodium chloride symporter inhibitors
antihypertensive agents
quinapril and diuretics
evaluation of the transparency committee
Quinapril

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/101-103HardyMC0502.pdf
2002
false
true
false
Canada
French
drug combinations
journal article
aspirin
acute coronary syndrome
Clopidogrel

---
https://iris.who.int/discover?query=Combinaisons%20therapeutiques%20antipaludiques
2001
Switzerland
French
malaria
antimalarials
drug combinations
africa
practice guideline

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.